What is the indication for the tablet containing Rose Hip 275 mg, Collagen Peptide 40 mg, Sodium Hyaluronate 30 mg, and Vitamin C 33.33 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Indication for Rose Hip, Collagen Peptide, Sodium Hyaluronate, and Vitamin C Combination Tablet

This combination tablet is marketed as a dietary supplement for skin health and anti-aging, specifically targeting skin hydration, elasticity, wrinkle reduction, and overall skin appearance—NOT for osteoarthritis treatment.

Primary Indication: Dermatological/Cosmetic Use

The formulation combines ingredients studied for skin health benefits:

Individual Component Evidence

Rose Hip (275 mg):

  • Contains high levels of vitamin C and bioactive compounds
  • Studied for wound healing, collagen synthesis, and anti-aging effects 1
  • Traditional use in skincare for scarring, hyperpigmentation, and wrinkles
  • Exhibits antioxidant and antimicrobial properties against skin bacteria

Collagen Peptide (40 mg):

  • Multiple randomized controlled trials demonstrate efficacy for skin parameters 2, 3, 4
  • Improves skin hydration, elasticity, roughness, and density when supplemented at 2.5-5g daily 3
  • The 40mg dose in this formulation is substantially lower than evidence-based doses (typically 2,500-5,000mg daily)
  • Effects include wrinkle reduction and improved skin texture 5, 4

Sodium Hyaluronate (30 mg):

  • When combined with collagen and vitamin C, one study showed benefits for dermis density and skin texture 2
  • However, the same study found no superior effects when hyaluronic acid was added to collagen alone 2
  • The oral bioavailability and efficacy at this low dose (30mg) lacks robust evidence

Vitamin C (33.33 mg):

  • Essential for collagen synthesis
  • Combined with collagen peptides shows synergistic effects on collagen deposition and expression 6
  • The dose provided (33.33mg) is below the typical supplementation range (80-100mg) used in skin studies 2, 3

Critical Limitations

Dosing Concerns:

  • The collagen peptide dose (40mg) is 60-125 times lower than evidence-based doses (2,500-5,000mg)
  • Vitamin C dose is suboptimal compared to studied formulations
  • No clinical trials exist for this specific combination at these doses

NOT Indicated for Osteoarthritis:

Major guidelines explicitly recommend AGAINST these ingredients for OA:

  • NICE guidelines (2008): "The use of glucosamine and chondroitin products is not recommended" and "intra-articular hyaluronan injections are not recommended" 7
  • EULAR guidelines (2005): Hyaluronic acid and similar agents have "small effect sizes, suitable patients are not well defined" 8
  • ACR/Arthritis Foundation (2020): Strongly recommends AGAINST chondroitin sulfate and conditionally recommends AGAINST intraarticular hyaluronic acid for knee/hip OA 9

Clinical Bottom Line

This product is a cosmetic/nutraceutical supplement intended for skin health support, not a therapeutic agent for joint disease. The evidence base supports skin-related benefits for the individual ingredients when used at higher doses than provided in this formulation. Patients seeking joint health benefits should be redirected to evidence-based OA treatments including exercise, weight management, paracetamol, and NSAIDs 7, 10, 9.

Common Pitfall: Patients may confuse this with joint health supplements due to the presence of collagen and hyaluronate. Clarify that oral collagen peptides for skin differ fundamentally from joint cartilage support, and current evidence does not support oral supplementation for OA management.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.